Weight-Loss Drug Frenzy Cements Novo Nordisk as Europe’s Most Valuable Company

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

España Noticias Noticias

España Últimas Noticias,España Titulares

Little more than a month since becoming Europe’s most valuable listed company, Novo Nordisk A/S has stretched its lead to almost $90 billion as the buzz around weight-loss drugs gets ever louder.

Israel Latest: IDF Urges Evacuation of Gaza City, Signaling IncursionSt.

James’s Place Says It’s Reviewing Fees; Shares TumbleBlackRock Clients Pull $13 Billion From Long-Term FundsBOE’s Bailey Seeks Ways to Respond Faster When Bank Runs HappenChina’s Credit Growth Beats Expectations on Stronger StimulusIMF Latest: World Bank Says Poorest Need More Funding Than EverUK’s FCA Fines Equifax £11 Million Over Massive Cyber HackNASA Probe Bound for Metal Asteroid to Launch on SpaceX’s Falcon HeavyFrom high flying to burnout, pot industry faces downturn five years...

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 83. in ES

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Clothing Stocks Seen as Latest Winners From Weight-Loss DrugsThe boom in weight-loss drugs is set to provide a boost to sportswear brands and clothing retailers, according to Deutsche Bank AG analysts.
Fuente: BNNBloomberg - 🏆 83. / 50 Leer más »